2024-09-01 2025-08-31 2025-08-31 false 13566902 ASSUREBIO LTD 2026-02-17 78109 false iso4217:GBP xbrli:pure 13566902 2024-08-31 13566902 2025-08-31 13566902 2024-09-01 2025-08-31 13566902 2023-08-31 13566902 2024-08-31 13566902 2023-09-01 2024-08-31 13566902 bus:SmallEntities 2024-09-01 2025-08-31 13566902 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 13566902 bus:FullAccounts 2024-09-01 2025-08-31 13566902 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 13566902 core:WithinOneYear 2025-08-31 13566902 core:AfterOneYear 2025-08-31 13566902 core:WithinOneYear 2024-08-31 13566902 core:AfterOneYear 2024-08-31 13566902 core:ShareCapital 2025-08-31 13566902 core:SharePremium 2025-08-31 13566902 core:RevaluationReserve 2025-08-31 13566902 core:OtherReservesSubtotal 2025-08-31 13566902 core:RetainedEarningsAccumulatedLosses 2025-08-31 13566902 core:ShareCapital 2024-08-31 13566902 core:SharePremium 2024-08-31 13566902 core:RevaluationReserve 2024-08-31 13566902 core:OtherReservesSubtotal 2024-08-31 13566902 core:RetainedEarningsAccumulatedLosses 2024-08-31 13566902 core:LandBuildings 2025-08-31 13566902 core:PlantMachinery 2025-08-31 13566902 core:Vehicles 2025-08-31 13566902 core:FurnitureFittings 2025-08-31 13566902 core:OfficeEquipment 2025-08-31 13566902 core:NetGoodwill 2025-08-31 13566902 core:IntangibleAssetsOtherThanGoodwill 2025-08-31 13566902 core:ListedExchangeTraded 2025-08-31 13566902 core:UnlistedNon-exchangeTraded 2025-08-31 13566902 core:LandBuildings 2024-08-31 13566902 core:PlantMachinery 2024-08-31 13566902 core:Vehicles 2024-08-31 13566902 core:FurnitureFittings 2024-08-31 13566902 core:OfficeEquipment 2024-08-31 13566902 core:NetGoodwill 2024-08-31 13566902 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 13566902 core:ListedExchangeTraded 2024-08-31 13566902 core:UnlistedNon-exchangeTraded 2024-08-31 13566902 core:LandBuildings 2024-09-01 2025-08-31 13566902 core:PlantMachinery 2024-09-01 2025-08-31 13566902 core:Vehicles 2024-09-01 2025-08-31 13566902 core:FurnitureFittings 2024-09-01 2025-08-31 13566902 core:OfficeEquipment 2024-09-01 2025-08-31 13566902 core:NetGoodwill 2024-09-01 2025-08-31 13566902 core:IntangibleAssetsOtherThanGoodwill 2024-09-01 2025-08-31 13566902 core:ListedExchangeTraded 2024-09-01 2025-08-31 13566902 core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 13566902 core:MoreThanFiveYears 2024-09-01 2025-08-31 13566902 core:Non-currentFinancialInstruments 2025-08-31 13566902 core:Non-currentFinancialInstruments 2024-08-31 13566902 dpl:CostSales 2024-09-01 2025-08-31 13566902 dpl:DistributionCosts 2024-09-01 2025-08-31 13566902 core:LandBuildings 2024-09-01 2025-08-31 13566902 core:PlantMachinery 2024-09-01 2025-08-31 13566902 core:Vehicles 2024-09-01 2025-08-31 13566902 core:FurnitureFittings 2024-09-01 2025-08-31 13566902 core:OfficeEquipment 2024-09-01 2025-08-31 13566902 dpl:AdministrativeExpenses 2024-09-01 2025-08-31 13566902 core:NetGoodwill 2024-09-01 2025-08-31 13566902 core:IntangibleAssetsOtherThanGoodwill 2024-09-01 2025-08-31 13566902 dpl:GroupUndertakings 2024-09-01 2025-08-31 13566902 dpl:ParticipatingInterests 2024-09-01 2025-08-31 13566902 dpl:GroupUndertakings core:ListedExchangeTraded 2024-09-01 2025-08-31 13566902 core:ListedExchangeTraded 2024-09-01 2025-08-31 13566902 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 13566902 core:UnlistedNon-exchangeTraded 2024-09-01 2025-08-31 13566902 dpl:CostSales 2023-09-01 2024-08-31 13566902 dpl:DistributionCosts 2023-09-01 2024-08-31 13566902 core:LandBuildings 2023-09-01 2024-08-31 13566902 core:PlantMachinery 2023-09-01 2024-08-31 13566902 core:Vehicles 2023-09-01 2024-08-31 13566902 core:FurnitureFittings 2023-09-01 2024-08-31 13566902 core:OfficeEquipment 2023-09-01 2024-08-31 13566902 dpl:AdministrativeExpenses 2023-09-01 2024-08-31 13566902 core:NetGoodwill 2023-09-01 2024-08-31 13566902 core:IntangibleAssetsOtherThanGoodwill 2023-09-01 2024-08-31 13566902 dpl:GroupUndertakings 2023-09-01 2024-08-31 13566902 dpl:ParticipatingInterests 2023-09-01 2024-08-31 13566902 dpl:GroupUndertakings core:ListedExchangeTraded 2023-09-01 2024-08-31 13566902 core:ListedExchangeTraded 2023-09-01 2024-08-31 13566902 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-31 13566902 core:UnlistedNon-exchangeTraded 2023-09-01 2024-08-31 13566902 core:NetGoodwill 2025-08-31 13566902 core:IntangibleAssetsOtherThanGoodwill 2025-08-31 13566902 core:LandBuildings 2025-08-31 13566902 core:PlantMachinery 2025-08-31 13566902 core:Vehicles 2025-08-31 13566902 core:FurnitureFittings 2025-08-31 13566902 core:OfficeEquipment 2025-08-31 13566902 core:AfterOneYear 2025-08-31 13566902 core:WithinOneYear 2025-08-31 13566902 core:ListedExchangeTraded 2025-08-31 13566902 core:UnlistedNon-exchangeTraded 2025-08-31 13566902 core:ShareCapital 2025-08-31 13566902 core:SharePremium 2025-08-31 13566902 core:RevaluationReserve 2025-08-31 13566902 core:OtherReservesSubtotal 2025-08-31 13566902 core:RetainedEarningsAccumulatedLosses 2025-08-31 13566902 core:NetGoodwill 2024-08-31 13566902 core:IntangibleAssetsOtherThanGoodwill 2024-08-31 13566902 core:LandBuildings 2024-08-31 13566902 core:PlantMachinery 2024-08-31 13566902 core:Vehicles 2024-08-31 13566902 core:FurnitureFittings 2024-08-31 13566902 core:OfficeEquipment 2024-08-31 13566902 core:AfterOneYear 2024-08-31 13566902 core:WithinOneYear 2024-08-31 13566902 core:ListedExchangeTraded 2024-08-31 13566902 core:UnlistedNon-exchangeTraded 2024-08-31 13566902 core:ShareCapital 2024-08-31 13566902 core:SharePremium 2024-08-31 13566902 core:RevaluationReserve 2024-08-31 13566902 core:OtherReservesSubtotal 2024-08-31 13566902 core:RetainedEarningsAccumulatedLosses 2024-08-31 13566902 core:NetGoodwill 2023-08-31 13566902 core:IntangibleAssetsOtherThanGoodwill 2023-08-31 13566902 core:LandBuildings 2023-08-31 13566902 core:PlantMachinery 2023-08-31 13566902 core:Vehicles 2023-08-31 13566902 core:FurnitureFittings 2023-08-31 13566902 core:OfficeEquipment 2023-08-31 13566902 core:AfterOneYear 2023-08-31 13566902 core:WithinOneYear 2023-08-31 13566902 core:ListedExchangeTraded 2023-08-31 13566902 core:UnlistedNon-exchangeTraded 2023-08-31 13566902 core:ShareCapital 2023-08-31 13566902 core:SharePremium 2023-08-31 13566902 core:RevaluationReserve 2023-08-31 13566902 core:OtherReservesSubtotal 2023-08-31 13566902 core:RetainedEarningsAccumulatedLosses 2023-08-31 13566902 core:AfterOneYear 2024-09-01 2025-08-31 13566902 core:WithinOneYear 2024-09-01 2025-08-31 13566902 core:Non-currentFinancialInstruments core:CostValuation 2024-09-01 2025-08-31 13566902 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-09-01 2025-08-31 13566902 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-09-01 2025-08-31 13566902 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-09-01 2025-08-31 13566902 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 13566902 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 13566902 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 13566902 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 13566902 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-09-01 2025-08-31 13566902 core:Non-currentFinancialInstruments core:CostValuation 2025-08-31 13566902 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-08-31 13566902 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-08-31 13566902 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-08-31 13566902 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-08-31 13566902 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-08-31 13566902 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-08-31 13566902 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-08-31 13566902 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-08-31 13566902 core:Non-currentFinancialInstruments core:CostValuation 2024-08-31 13566902 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-08-31 13566902 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-08-31 13566902 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-08-31 13566902 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-08-31 13566902 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-08-31 13566902 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-08-31 13566902 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-08-31 13566902 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-08-31 13566902 bus:Director1 2024-09-01 2025-08-31

ASSUREBIO LTD

Registered Number
13566902
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2025

ASSUREBIO LTD
Company Information
for the year from 1 September 2024 to 31 August 2025

Director | PAWAR, Daljeet

Registered Address | 7 Bell Yard
| Lower Ground Floor
| London
| WC2A 2JR

Registered Number | 13566902 (England and Wales)

ASSUREBIO LTD
Balance Sheet as at
31 August 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 335 |  |  |  | -
|  |  |  | 335 |  |  |  | -
Current assets |  |  |  |  |  |  |  |
Debtors |  | 36,305 |  |  |  | 4,567 |  |
Cash at bank and on hand |  | 712,265 |  |  |  | 630,526 |  |
|  | 748,570 |  |  |  | 635,093 |  |
Creditors amounts falling due within one year | 4 | (132,491) |  |  |  | (170,029) |  |
Net current assets (liabilities) |  |  |  | 616,079 |  |  |  | 465,064
Total assets less current liabilities |  |  |  | 616,414 |  |  |  | 465,064
Net assets |  |  |  | 616,414 |  |  |  | 465,064
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 10 |  |  |  | -
Profit and loss account |  |  |  | 616,404 |  |  |  | 465,064
Shareholders' funds |  |  |  | 616,414 |  |  |  | 465,064

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 17 February 2026, and are signed on its behalf by:
PAWAR, Daljeet Director Registered Company No. 13566902

ASSUREBIO LTD
Notes to the Financial Statements
for the year ended 31 August 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Revenue from rendering of services
--- | ---
| Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

| Employee benefits
--- | ---
| Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Tangible fixed assets and depreciation
--- | ---
| All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

|  | Straight line (years)
| Office Equipment | 3

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 0 |  | 0

3. | Tangible fixed assets
--- | ---

|  | Office Equipment |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| Additions | 345 |  | 345
| At 31 August 25 | 345 |  | 345
| Depreciation and impairment
| Charge for year | 10 |  | 10
| At 31 August 25 | 10 |  | 10
| Net book value
| At 31 August 25 | 335 |  | 335
| At 31 August 24 | - |  | -

4. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 9,063 |  | 25,323
| Taxation and social security | 123,428 |  | 144,706
| Total | 132,491 |  | 170,029